Talk:Rifampicin/isoniazid/pyrazinamide

Pharmacology Mid‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
Mid	This article has been rated as Mid-importance on the project's importance scale.

Medicine Mid‑importance

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine articles
Mid	This article has been rated as Mid-importance on the project's importance scale.

Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Rifampicin/isoniazid/pyrazinamide.

PubMed provides review articles from the past five years (limit to free review articles)
The TRIP database provides clinical publications about evidence-based medicine.
Other potential sources include: Centre for Reviews and Dissemination and CDC

What classification of drug is Rifater — Preceding unsigned comment added by 143.110.24.185 (talk) 14:36, 23 April 2007

It is a combination of antimycobacterials. Under the Anatomical Therapeutic Chemical Classification System, it is a Combination of drugs for treatment of tuberculosis (ATC code J04AM). Fvasconcellos (t·c) 14:53, 23 April 2007 (UTC)[reply]

Rifampicine[edit]

⛛ Cirose (talk) 17:51, 4 April 2020 (UTC)[reply]